Replies to post #459952 on Anavex Life Sciences Corp (AVXL)

[kund]

Chatgpt doesn't learn from user data, response was based on what ever it learned/trained in 2023.

As of my last update in 2023, Anavex Life Sciences has been conducting clinical trials for their drug candidate, Anavex 2-73 (blarcamesine), targeting Alzheimer's disease (AD) and other neurological disorders. The results from these trials have garnered attention and mixed reactions.